A stable liposomal formulation for ocular delivery. The formulation contains a liposome that includes at least one lipid bilayer containing a phosphatidylcholine, and a prostaglandin F2α encapsulated in the liposome. The formulation is useful for treating an ocular disorder with the formulation.